Back
The Estee Lauder Companies Vs. Monopar Therapeutics Industry Stock Comparison
Sell
30
EL
The Estee Lauder Companies
Last Price:
74.97
Seasonality Move:
6%
Buy
75
MNPR
Monopar Therapeutics
Last Price:
29.73
Seasonality Move:
35.55%
Sell
30
The Estee Lauder Companies (EL)
is a Sell
Is The Estee Lauder Companies a Buy, Sell or Hold?
- The current The Estee Lauder Companies [EL] share price is $78.18. The Score for EL is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- EL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
75
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy, Sell or Hold?
- The current Monopar Therapeutics [MNPR] share price is $30.68. The Score for MNPR is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
EL Stock Price Chart
What is The Estee Lauder Companies's stock price today?
-
The The Estee Lauder Companies share price today is $78.18
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EL is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
EL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.63 | Buy |
| Relative Strength Index (14 RSI): | 53.56 | Buy |
| Chaikin Money Flow: | -3446748 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.49 - 80.11) | Buy |
| Bollinger Bands (100): | (74.18 - 96.14) | Sell |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.92 | Buy |
| Relative Strength Index (14 RSI): | 76.63 | Buy |
| Chaikin Money Flow: | 62338 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.5 - 24.7) | Buy |
| Bollinger Bands (100): | (1.59 - 18.41) | Buy |
EL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.45 | Sell |
| 20-day SMA: | 75.68 | Buy |
| 50-day SMA: | 78.1 | Buy |
| 200-day SMA: | 107.17 | Sell |
| 8-day EMA: | 79.32 | Sell |
| 20-day EMA: | 77.13 | Buy |
| 50-day EMA: | 78.83 | Sell |
| 200-day EMA: | 102.82 | Sell |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.74 | Buy |
| 20-day SMA: | 22.43 | Buy |
| 50-day SMA: | 16.57 | Buy |
| 200-day SMA: | 6.79 | Buy |
| 8-day EMA: | 25.62 | Buy |
| 20-day EMA: | 22.75 | Buy |
| 50-day EMA: | 17.67 | Buy |
| 200-day EMA: | 9.07 | Buy |
The Estee Lauder Companies Earnings Growth & EL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.12 per share, and a decrease next year of $0.65 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.58 per share, and a decrease next year of $0.91 per share.
The Estee Lauder Companies Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||